UHealth - University of Miami Health System

E-mail a Friend

Carlos Singer, M.D.

General Information

Carlos  Singer, M.D.



  • Neurology (Psychiatry & Neurology)


English, Spanish

Clinical Areas

Parkinson's disease, movement disorders, botulinum toxin administration for movement disorders


  • Neurology (American Board of Psychiatry & Neurology)
  • American Board of Internal Medicine


  • Chief, Movement Disorders Division
  • Professor of Neurology

Research Interests

Clinical trials for Parkinson's disease, clinical trials for Huntington's disease, clinical trials for dystonia



1989 Fellowship
University of Miami School of Medicine
1981 Fellowship
Jackson Memorial Hospital, University of Miami - Affiliated Medical Education Program
1979 Residency
Albert Einstein College of Medicine
1972 M.D.
Central Univeristy of Venezuela School of Medicine


Dr. Carlos Singer is Professor of Neurology and Director of the Division of Parkinson's Disease and Movement Disorders, designated as a National Parkinson Foundation Center of Excellence. He received his medical degree from the Central University of Venezuela in 1972. This was followed by training in Internal Medicine at the University of Pittsburg and in Neurology at the Albert Einstein College of Medicine Affiliated Hospitals. Dr. Singer received additional training in Electromyography and in Movement Disorders at the University of Miami. Dr. Singer is board certified in both Internal Medicine and Neurology. He has been a member of the faculty of the Department of Neurology of the Miller School of Medicine/University of Miami since 1989.  Dr. Singer's special interest is in the non-motor manifestations of Parkinson's Disease such as urological, cardiovascular and other aspects of this disease.  He chairs the working group on "Non-Motor Manifestations of Parkinson Disease' of the Parkinson Study Group. He is a member of the American Academy of Neurology, the American Neurological Association, the Movement Disorders Society, the Parkinson Study Group, the Huntington Study Group and the Dystonia Study Group.  He also established the first Botulinum toxin Treatment Program for neurological disorders in Florida in 1990.  Dr. Singer is planning further expansion of the Center's clinical, research, outreach and educational activities.   

E-mail a Friend